Professor Chris McDermott
MBChB, FRCP, PhD
School of Medicine and Population Health
Professor of Translational Neurology
Honorary Consultant Neurologist
+44 114 222 2262
Full contact details
School of Medicine and Population Health
Sheffield Institute for Translational Neuroscience (SITraN)
385a Glossop Road
Sheffield
S10 2HQ
- Profile
-
Prof McDermott studied for his medical degree at the University in Leeds graduating in 1994. He then continued is general medical and specialist neurology training in Leeds before taking up a clinical research training fellowship at the University of Newcastle upon Tyne.
He moved to the University of Sheffield with Professor Dame Pamela Shaw in 2000 to undertake his Wellcome Trust Research Training PhD Fellowship and to complete his Specialist Training in Neurology to become a Consultant Neurologist in 2006. Prof McDermott is now the Professor of Translational Neurology at SITraN, an NIHR Research Professor and a Consultant Neurologist at the Sheffield Teaching Hospitals Foundation NHS Trust regularly undertaking specialist 51ݶ and neuromuscular clinics in Sheffield.
The main drive of Prof McDermott’s research programme is evaluating the new treatments for motor neuron disease. He is also passionate about developing the evidence base for delivering supportive and symptomatic care for patients living with motor neuron disease now.
- Qualifications
-
2021 – to date
NIHR Research Professor
2018 - 2022
Professor of Translational Neurology
Head of Department2017 – to date
Professor of Translational Neurology
Academic Director for Neuroscience, Sheffield Teaching Hospitals NHS Foundation Trust2006 - 2013
Clinical Senior Lecturer in Neurology2002 - 2006
Specialist Training in Neurology (CCT), Sheffield
2000 - 2002
Wellcome Trust Research Training Fellowship (PhD), University of Sheffield
1998 - 2000
Clinical Research Fellow, University of Newcastle upon Tyne
1997 - 1998
Specialist Training in Neurology, Leeds
1994 - 1997
General professional training (MRCP), Leeds Teaching Hospitals
1989 - 1994
Medicine (MBChB), University of Leeds
- Research interests
-
Current Projects
- Designing and conducting clinical trials in 51ݶ
- Collaborating with pharmaceutical companies in Phase 1-3 studies
- Improving symptomatic management for patients with 51ݶ
- Developing and evaluating novel service delivery mechanisms for patients with 51ݶ and long term neurological conditions
- Investigating optimal respiratory support for patients with 51ݶ
- Establishing an evidence base for nutritional support in 51ݶ
- Exploring the role of the microbiome in 51ݶ
- Designing and evaluating assistive technologies for patients with neuromuscular weakness
- Genetic and phenotypic characterisation of motor system disorders
- Natural history study of motor system disorders
- Designing and conducting clinical trials in 51ݶ
- Collaborating with pharmaceutical companies in Phase 1-3 studies
- Improving symptomatic management for patients with 51ݶ
- Epidemiology of motor neuron disease
- Publications
-
Journal articles
- . Neuromuscular Disorders, 65, 106470-106470.
- . Clinical Nutrition ESPEN, 103360-103360.
- . Implementation Science Communications.
- . Journal of Rock Mechanics and Geotechnical Engineering.
- . Muscle and Nerve.
- . Clinical Neurophysiology, 185, 2111164-2111164.
- . Clinical Neurophysiology, 185, 2111362-2111362.
- . Clinical Neurophysiology, 185, 2111107-2111107.
- . Muscle & Nerve.
- . Amyotroph Lateral Scler Frontotemporal Degener, 1-5.
- . Neurodegener Dis Manag, 1-10.
- . Journal of Genetic Counseling, 35(1).
- . Neurodegenerative Disease Management.
- . JAMA Neurology, 83(2).
- . Muscle & Nerve, 73(5), 832-842.
- . Amyotroph Lateral Scler Frontotemporal Degener, 1-3.
- . Alzheimer's & Dementia, 21(S4).
- Understanding Patient and Caregiver Attitudes Towards Cognitive and Behavioural Screening in Amyotrophic Lateral Sclerosis. Alzheimer's & dementia : the journal of the Alzheimer's Association, 21(Suppl 4).
- . eBioMedicine, 122, 106029-106029.
- . eBioMedicine, 121, 105962-105962.
- . Health Technology Assessment, 29(51), 1-28.
- . Health and Quality of Life Outcomes, 23(1).
- . Disability and Rehabilitation.
- . Health Expectations, 28(5).
- Optimising Calorie Intake for People With Amyotrophic Lateral Sclerosis: A Process Evaluation of a Complex Behaviour Change Intervention. Health expectations : an international journal of public participation in health care and health policy, 28(5).
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration.
- . Amyotrophic lateral sclerosis and frontotemporal degeneration.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration.
- . Amyotroph Lateral Scler Frontotemporal Degener, 1-7.
- . Journal of Genetic Counseling, 34(4).
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration.
- . Quality of Life Research.
- . Neurology, 105(1).
- . Geomechanics for Energy and the Environment, 42, 100685-100685.
- . BMJ Open, 15(5).
- . Muscle & Nerve.
- . Neurodegenerative Disease Management, 15(4), 149-160.
- . The Lancet, 405(10492), 1837-1850.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 26(sup 1), 20-29.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 26(sup1), 50-60.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 26(sup 1), 30-40.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 26(sup1), 8-19.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 26(sup 1), 41-49.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 26(sup1), 61-72.
- . Journal of Medical Internet Research, 27.
- . Brain, 148(11), 4000-4015.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 26(5-6), 599-603.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 26(5-6), 507-515.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 26(5-6), 467-477.
- . Muscle & Nerve, 71(6), 1006-1015.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 26(5-6).
- . Brain, 148(6).
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 26(3-4), 249-258.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 26(3-4), 192-202.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 26(3-4), 385-388.
- . Brain, 148(4), 1106-1111.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 26(1-2), 181-185.
- . Nutrition Reviews, 83(5), 943-960.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 26(3-4), 225-238.
- . Journal of Neurology, 272(1).
- . The Cognitive Behaviour Therapist, 17.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 26(3-4), 331-342.
- . JMIR Research Protocols, 13.
- . The Lancet Neurology, 23(11), 1097-1107.
- . Health and Quality of Life Outcomes, 22(1).
- . European Journal of Neurology, 31(9).
- . Neurology, 103(2).
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 25(7-8), 661-671.
- . PharmacoEconomics, 42(9), 1003-1016.
- , 119-169.
- . The Lancet.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 25(5-6), 648-652.
- . European Journal of Neurology, 31(8).
- . Geoenergy, 2(1).
- . The Analyst, 149(9), 2738-2746.
- . European Journal of Neurology, 31(6).
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 1-11.
- . Journal of Medical Genetics, 61(7), 661-665.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 25(3-4), 400-409.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 25(3-4), 382-387.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 25(3-4), 290-298.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 25(3-4), 410-412.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 25(3-4), 420-423.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 25(3-4), 416-419.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 25(1-2), 16-25.
- . Trials, 24(1).
- . Translational Neurodegeneration, 12(1).
- . Clinical Nutrition ESPEN, 57, 839-839.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 24(7-8), 641-650.
- . Clinical Nutrition ESPEN, 57, 739-748.
- . Nature Reviews Neurology, 19(9), 511-524.
- . Pilot and Feasibility Studies, 9.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 24(7-8), 605-613.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 24(7-8), 766-770.
- . Health Expectations, 26(4), 1418-1435.
- . European Journal of Neurology, 30(9), 2595-2601.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 24(5-6), 389-393.
- . Neurology, 100(23).
- . ERJ Open Research, 9(2).
- . Trials, 24.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 24(5-6), 553-557.
- . Journal of Raman Spectroscopy, 54(3), 258-268.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 24(5-6), 548-552.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 24(3-4), 272-280.
- . Journal of the Neurological Sciences, 444, 120483-120483.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 24(5-6), 544-547.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 24(1-2), 82-90.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 24(3-4), 351-357.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 24(5-6), 539-543.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 24(1-2), 63-70.
- . Chronic Illness, 19(2), 368-382.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 24(1-2), 159-163.
- . BMC Neurology, 22(1).
- . Frontiers in Neurology, 13.
- . New England Journal of Medicine, 387(12), 1099-1110.
- . Journal of Medical Engineering & Technology, 46(6), 518-526.
- . Journal of Neurology, 269(11), 6003-6013.
- . BMJ Open, 12(6).
- . Clinical Neurophysiology, 139, 69-75.
- . Analyst, 2022(11), 2533-2540.
- . European Journal of Human Genetics, 30(6), 635-636.
- . Clinical Nutrition ESPEN, 49, 328-340.
- . Brain Communications, 4(2).
- . Journal of Medical Engineering & Technology, 46(6), 506-517.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 2022, 1-9.
- . Annals of Neurology, 91(4), 521-531.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 23(7-8), 481-488.
- . Brain Communications, 4(1).
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 23(5-6), 363-371.
- . Clinical Neurophysiology, 138, 231-240.
- . Brain, 145(3), 832-842.
- . Journal of Raman Spectroscopy, 53(2), 172-181.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 23(5-6), 390-398.
- . Muscle & Nerve, 65(2), 203-210.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 23(3-4), 242-251.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 23(5-6), 476-479.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 23(3-4), 315-319.
- . Physiological Measurement, 42(10).
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 22(7-8), 495-504.
- . Neurology, 97(11), 528-536.
- . Journal of Medical Internet Research, 23(9).
- . Brain Sciences, 11(8).
- . Journal of Human Nutrition and Dietetics, 34(6), 1064-1071.
- . Journal of Neurology, Neurosurgery & Psychiatry, 92(5), 510-518.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 22(3-4), 300-307.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 22(5-6), 350-359.
- . BMC Medicine, 19(1).
- . Journal of the Neurological Sciences, 421, 117285-117285.
- . Nature Reviews Neurology, 17(2), 104-118.
- . Journal of Neurology, Neurosurgery & Psychiatry, 92(2), 117-117.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 22(7-8), 592-594.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 22(3-4), 316-319.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 22(1-2), 154-160.
- . Brain, 143(12), 3603-3618.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 22(7-8), 579-582.
- . Physiological Measurement, 41(12).
- . Clinical Nutrition ESPEN, 40, 519-519.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 22(1-2), 38-45.
- . Clinical Nutrition, 39(8), 2547-2556.
- . New England Journal of Medicine, 383(2), 109-119.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 21(7-8), 496-501.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 21(5-6), 364-372.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 21(7-8), 642-647.
- . Clinical Neurophysiology, 131(4), 799-808.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 21(3-4), 314-319.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 21(5-6), 477-483.
- . Clinical Nutrition ESPEN, 35, 235-235.
- . Journal of Neurology, 267(3), 616-617.
- . Journal of Neurology, 267(1), 244-256.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 21(1-2), 154-157.
- . Journal of Neurology, 267(3), 607-615.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 21(1-2), 150-153.
- . Developmental Medicine & Child Neurology, 62(3), 270-270.
- . Journal of Neurology, Neurosurgery & Psychiatry, 91(1), 7-7.
- . JOURNAL OF NEUROLOGY.
- . BMJ Open, 9(12).
- . British Journal of Health Psychology, 24(4), 953-969.
- . BMJ Open, 9(10).
- . BMJ Open, 9.
- . Current Opinion in Neurology, 32(5), 758-763.
- . European Respiratory Journal, 54(3).
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 20(7-8), 511-520.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 20(7-8), 521-531.
- . Practical Neurology, 19(6), 467-475.
- . Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, 20(7-8), 461-472.
- . Neurology, 93(1).
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 20(7-8), 625-629.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 20(5-6), 317-327.
- . Acta Neurologica Scandinavica, 140(2), 131-139.
- . Neurology, 92(15_supplement).
- . Neurology, 92(15_supplement).
- . Neurology, 92(15_supplement).
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 20(7-8), 619-624.
- . Neurology, 92(14), e1610-e1623.
- . Cell Reports, 26(9), 2298-2306.e5.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 20(1-2), 74-81.
- . The Lancet Neurology, 18(3), 259-268.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 20(1-2), 126-131.
- . Disability and Rehabilitation: Assistive Technology, 14(7), 675-681.
- . Neurology Genetics, 4(6).
- . Brain, 141(10), 2866-2877.
- . Clinical Biomechanics, 57, 114-120.
- . Lancet Neurology, 17(5), 423-433.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 19(7-8), 630-634.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 19(7-8), 623-629.
- . Acta Neurologica Scandinavica, 138(1), 47-54.
- . Journal of Neuromuscular Diseases, 5(1), 107-107.
- . Journal of Neurology, Neurosurgery and Psychiatry, 89, 248-255.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 19(5-6), 351-361.
- . Ergonomics, 61(2), 329-338.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 19(5-6), 472-476.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 19(3-4), 317-319.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 19(1-2), 157-160.
- . Journal of Neurology, Neurosurgery & Psychiatry, 88(Suppl 1), A63.4-A64.
- . Frontiers in Molecular Neuroscience, 10.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 18(7-8), 471-474.
- . Neurology, 89(18), 1915-1922.
- . Practical Neurology, 17(5), 339-340.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 18(7-8), 627-631.
- . Journal of the Peripheral Nervous System, 22(2), 68-76.
- . BMJ Support Palliat Care, 7(2), 189-196.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 18(5-6), 313-323.
- . BMC Health Services Research, 17.
- . Practical Neurology, 17(2), 96-103.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 18(5-6), 466-469.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 18(5-6), 378-387.
- . BMJ Supportive and Palliative Care.
- . PLoS One, 12(1).
- . Amyotroph Lateral Scler Frontotemporal Degener.
- . Cochrane Database of Systematic Reviews, 2016(12).
- . Medicine, 44(9), 552-556.
- . Muscle and Nerve.
- . Nature Reviews Neurology, 12(9), 526-538.
- . Health Technology Assessment, 20(45), 1-186.
- . European Journal of Neurology, 23(6), 1071-1078.
- . Neuropathology , 36(2), 125-134.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 17(5-6), 325-336.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 17(5-6), 313-324.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 17(5-6), 377-384.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration .
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 17(3-4), 305-306.
- . Practical Neurology, 16(3), 227-230.
- . Clinical Biomechanics, 32, 201-206.
- . BMJ Support Palliat Care, 6(1), 52-59.
- . The Lancet Neurology, 14(12), 1153-1153.
- . Environmental Earth Sciences, 74(12), 7837-7854.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 16(7-8), 448-455.
- . Journal of Medical Engineering & Technology, 39(7), 404-410.
- . Lancet Neurology, 14(9), 883-892.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 16(7-8), 478-484.
- . Lancet Neurology, 14(7), 702-709.
- . The Lancet Neurology, 14(7), 690-690.
- . Neuropathol Appl Neurobiol, 41(2), 201-226.
- . Current Opinion in Neurology, 27(5), 524-531.
- . Neuropathol Appl Neurobiol, 40(6), 670-685.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 16(1-2), 108-113.
- . BMJ Supportive & Palliative Care, 4(Suppl 1), A39.1-A39.
- . BMJ Supportive & Palliative Care, 4(Suppl 1), A25.1-A25.
- . BMJ Support Palliat Care, 4(1), 57-63.
- . Acta Neuropathol, 127(3), 407-418.
- . Dis Model Mech, 7(1), 73-81.
- . J Palliat Med, 16(12), 1602-1609.
- . Palliat Med, 27(9), 878.
- . Neuro Ophthalmology, 37(4), 146-156.
- . Neurology, 81(9), 808-811.
- . Neuropathol Appl Neurobiol, 39(5), 562-571.
- . Amyotroph Lateral Scler Frontotemporal Degener, 14(5-6), 414-423.
- . Amyotroph Lateral Scler Frontotemporal Degener, 14(7-8), 521-527.
- . Palliat Med, 27(6), 516-523.
- . Lancet Neurology, 12(4), 339-345.
- . Journal of Rock Mechanics and Geotechnical Engineering, 5(1), 1-17.
- . Journal of Rock Mechanics and Geotechnical Engineering, 5(1), 44-57.
- . J Neurol Neurosurg Psychiatry, 84(1), 79-87.
- . Amyotroph Lateral Scler Frontotemporal Degener, 14(2), 96-104.
- . Amyotroph Lateral Scler Frontotemporal Degener, 14(2), 105-110.
- . Amyotroph Lateral Scler Frontotemporal Degener, 14(1), 13-19.
- . BMC Neurol, 12, 74.
- . Amyotroph Lateral Scler, 13(6), 528-532.
- . Pract Neurol, 12(3), 166-176.
- . Journal of Neurology, Neurosurgery & Psychiatry, 83(4), 368-369.
- . BMJ Supportive & Palliative Care, 2(Suppl 1), A102.3-A103.
- . Brain, 135(Pt 3), 751-764.
- . Medicine United Kingdom, 40(10), 540-545.
- . Journal of Neurology Neurosurgery and Psychiatry, 83(4), 371-376.
- . J Neurol Neurosurg Psychiatry, 83(4), 371-376.
- Multiple sclerosis and amyotrophic lateral sclerosis - what is the link? A case series of six patients. MULTIPLE SCLEROSIS JOURNAL, 17, S472-S472.
- . BMC Neurology, 11.
- . BRIT MED J, 341.
- Non-invasive ventilation in motor neurone disease: an update of current UK practice. IRISH J MED SCI, 179, S497-S498.
- . INT J BEHAV NUTR PHY, 7.
- . Amyotroph Lateral Scler, 11(6), 531-536.
- . J Neurol Neurosurg Psychiatry, 81(6), 646-649.
- . Arch Neurol, 67(4), 455-461.
- . Neurogenetics, 11(2), 217-225.
- . Amyotroph Lateral Scler, 10(4), 191-204.
- . InnovAiT: Education and inspiration for general practice, 2(9), 531-537.
- . Neurology, 72(17), 1534-1534.
- . The Lancet Neurology, 8(2), 158-164.
- . J Neurochem, 110(1), 34-44.
- . Neurogenetics, 10(2), 105-110.
- . Medicine, 36(12), 640-645.
- . Neurology, 70(19), 1717-1718.
- . Clinical Neurophysiology, 119, S111-S111.
- . BMJ, 336(7645), 658-662.
- . Hydrogeology Journal, 16(4), 613-627.
- . Handbook of Clinical Neurology, 82, 327-352.
- . Journal of Membrane Science, 292(1-2), 9-16.
- . HUM MUTAT, 28(7), 739-740.
- . Computational Geosciences, 11(1), 9-26.
- . Marine Ecology Progress Series, 320, 259-266.
- . Hum Mol Genet, 15(18), 2763-2771.
- . Neurology, 67(1), 45-51.
- . Hydrogeology Journal, 14(4), 485-498.
- . Environmental Geology, 47(7), 1017-1027.
- . Amyotroph Lateral Scler Other Motor Neuron Disord, 4(2), 96-99.
- , 435-462.
- . J Neuropathol Exp Neurol, 62(11), 1166-1177.
- . Ann Neurol, 54(6), 748-759.
- . Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders, 4(2), 96-99.
- . Neuroreport, 14(3), 485-488.
- Investigation of mitochondrial function in hereditary spastic paraparesis. J NEUROL NEUROSUR PS, 73(2), 233-233.
- . Int Rev Neurobiol, 53, 191-204.
- . Neuroreport, 12(11), 2319-2322.
- . Neurology, 56(4), 467-471.
- Genotype-phenotype correlation in hereditary spastic paraparesis. J NEUROL NEUROSUR PS, 70(2), 270-270.
- . J Med Genet, 37(10), 759-765.
- . J Neurol Neurosurg Psychiatry, 69(2), 150-160.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 1-6.
- . JMIR Research Protocols, 15, e96327-e96327.
- . Journal of Health Psychology.
- . Muscle & Nerve.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 1-8.
- . Neurodegenerative Disease Management, 1-12.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 1-9.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 1-5.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 1-7.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 1-4.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 1-5.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 1-4.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 1-4.
- . Advances in Geosciences, 45, 185-192.
- . Practical Neurology, practneurol-2016.
- . Environmental Earth Sciences.
- . Cochrane Database of Systematic Reviews.
Book chapters
- , Public Policy in ALS/51ݶ Care (pp. 279-300). Springer Singapore
- , Nutrition in Neurologic Disorders (pp. 91-104). Springer International Publishing
Conference proceedings
- . Quality of Life Research, Vol. 33(Suppl 1) (pp S202-S202). Cologne, Germany, 13 October 2024 - 13 October 2024.
- . Neurology, Vol. 102(7_supplement_1)
- Developing a novel outcome measure to assess the impact of amyotrophic lateral sclerosis (ALS) on health-related quality of life (HRQoL): A study protocol. QUALITY OF LIFE RESEARCH, Vol. 33 (pp S111-S111)
- Galleries-to-Calories (G2C): An International Collaboration Evaluating Thermal Energy Storage in Abandoned Mines for District Heating. Transactions Geothermal Resources Council, Vol. 48 (pp 1905-1914)
- . Free Papers 18–20: Non-Malignant Disease (pp A8.1-A8)
- Discovering disease specific metabolites in Amyotrophic Lateral Sclerosis (ALS): new direction to personalised medicine?. EUROPEAN JOURNAL OF NEUROLOGY, Vol. 30 (pp 51-52)
- Feasibility of waste heat storage in flooded coal mines. 84th Eage Annual Conference and Exhibition, Vol. 4 (pp 2519-2523)
- . Clinical Nutrition ESPEN, Vol. 48 (pp 510-510). Brighton, UK, 30 November 2021 - 30 November 2021.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, Vol. 22(suppl 2) (pp 171-171). Virtual, 7 December 2021 - 7 December 2021.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, Vol. 22(sup2) (pp 232-233). Virtual conference, 7 December 2021 - 7 December 2021.
- Understanding Clinical Heterogeneity in Amyotrophic Lateral Sclerosis (ALS) - A Systematic Literature Review. EUROPEAN JOURNAL OF NEUROLOGY, Vol. 28 (pp 398-399)
- Variability in Mine Waste Mineralogy and Water Environment Risks: a Case Study on the River Almond Catchment, Scotland. PROCEEDINGS OF THE INTERNATIONAL MINE WATER ASSOCIATION CONFERENCE, IMWA 2021 (pp 181-187)
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, Vol. 20(suppl 1) (pp 310-310). Perth, Australia, 4 December 2019 - 4 December 2019.
- . Journal of Neurology, Neurosurgery & Psychiatry, Vol. 90(12) (pp e10.3-e11)
- . Journal of Neurology, Neurosurgery & Psychiatry, Vol. 90(12) (pp e55.4-e56)
- MUTATIONS IN THE GLYCOSYLTRANSFERASE DOMAIN OF GLT8D1 CAUSE ALS. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, Vol. 90(12) (pp E20-E21)
- Monitoring and promoting effectiveness and adherence to non-invasive ventilation in motor neurone disease using Encore Anywhere telemonitoring: a pilot and feasibility, randomised controlled trial. NEUROLOGY, Vol. 92(15)
- Predicting benign brachial monomelic amyotrophy: factors at presentation that differentiate from amyotropic lateral sclerosis. NEUROLOGY, Vol. 92(15)
- Investigating Directionality of Neurodegeneration in vivo in ALS using Multimodal MRI. NEUROLOGY, Vol. 92(15)
- Defining benign brachial monomelic amyotrophy: factors at presentation that differentiate from motor neurone disease. EUROPEAN JOURNAL OF NEUROLOGY, Vol. 26 (pp 307-307)
- . SEG Technical Program Expanded Abstracts 2018 (pp 3623-3627)
- . Annals of Physical and Rehabilitation Medicine, Vol. 61 (pp e521-e521)
- Imaging denervation in amyotrophic lateral sclerosis for future clinical trials: 12-month follow-up from a longitudinal cohort study. EUROPEAN JOURNAL OF NEUROLOGY, Vol. 25 (pp 302-302)
- Coupled THMC modelling of single fractures in novaculite and granite. 2nd International Discrete Fracture Network Engineering Conference Dfne 2018
- . Journal of the Neurological Sciences, Vol. 381 (pp 304-305). Kyoto, Japan, 16 September 2017 - 16 September 2017.
- . Journal of the Neurological Sciences , Vol. 381s (pp 102-102). Kyoto, Japan, 16 September 2017 - 16 September 2017.
- . Journal of the Neurological Sciences, Vol. 381 (pp 707-707)
- . Gait & Posture, Vol. 49 (pp S22-S22)
- The development of an evidence based guideline on the assessment and management of motor neurone disease/amyotrophic lateral sclerosis. EUROPEAN JOURNAL OF NEUROLOGY, Vol. 23 (pp 646-646)
- . Journal of Neurology, Neurosurgery and Psychiatry, Vol. 86(11). Institute of Education, London
- Elevated creatine kinase is associated with a better prognosis in patients with amyotrophic lateral sclerosis. Neurology, Vol. 22 (pp 741-741). Washington D.C., 18 April 2015 - 18 April 2015.
- . Journal of Neurology, Neurosurgery & Psychiatry, Vol. 85(10) (pp e4.93-e4)
- . Neurology, Vol. 82(10_supplement)
- . J Neurol Neurosurg Psychiatry, Vol. 84(11) (pp e2). England
- Neurodegeneration caused by intronic expansions of C9ORF72 is a clinically heterogeneous but pathologically distinct disease. LANCET, Vol. 381 (pp 32-32)
- . Mineralogical Magazine, Vol. 76(8) (pp 3131-3143)
- . JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, Vol. 83
- . JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, Vol. 83(3)
- . JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, Vol. 83(3)
- The Use of Non-Invasive Ventilation for Patients with Motor Neurone Disease: Patient and Carer Perceptions of Obstacles and Outcomes. ANNALS OF NEUROLOGY, Vol. 72 (pp S73-S74)
- The Environmental Legacy of Historic Mining Activities in the Almond River Catchment, Scotland. MINE WATER - MANAGING THE CHALLENGES: PROCEEDINGS OF THE INTERNATIONAL MINE WATER ASSOCIATION CONGRESS 2011 (pp 581-586)
- Modelling benchmark of a laboratory drying test in opalinus clay. Rock Mechanics in Civil and Environmental Engineering Proceedings of the European Rock Mechanics Symposium Eurock 2010 (pp 767-770)
- . JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, Vol. 81(11) (pp E50-E50)
- . Anaesthesia, Vol. 65(1) (pp 112-113)
- . JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, Vol. 80(11)
- CLINICAL AND NEUROPHYSIOLOGICAL SIMILARITIES BETWEEN TOXIC AND ACQUIRED INFLAMMATORY DEMYELINATING NEUROPATHIES: A REPORT OF TWO CASES. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, Vol. 80(1) (pp 123-123)
- CLINICAL AND NEUROPHYSIOLOGICAL FINDINGS IN HEREDITARY NEUROPATHY WITH LIABILITY TO PRESSURE PALSIES. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, Vol. 80(1) (pp 101-102)
- . Geological Society, London, Special Publications, Vol. 284(1) (pp 71-87)
- Reducing ambiguity in fractured-porous media characterization using single-well tracer tests. IAHS AISH Publication(304) (pp 17-24)
- Further insights into HSP and spastin: Severe complicated phenotypes and evidence of lower motor neurone dysfunction. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, Vol. 77(1) (pp 137-137)
- Hereditary spastic paraparesis associated with mutation in spastin (SPG4): A disorder of axonal transport?. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, Vol. 74(10) (pp 1453-1453)
- The results of screening all 17 exons of the spastin gene (SPG4) for autosomally dominantly transmitted Hereditary Spastic Paraplegia. JOURNAL OF MEDICAL GENETICS, Vol. 40 (pp S81-S81)
- Hereditary spastic paraparesis with amyotrophy and OXPHOS muscle defect associated with a deletion in the paraplegin (SPG7) gene with apparent autosomal dominant transmission. NEUROLOGY, Vol. 54(7) (pp A425-A425)
- . Critical Care Medicine, Vol. 15(4) (pp 400-400)
Reports
- NIV withdrawal guidance – published by Association of Palliative Medicine of GB and Northern Ireland.
Other
- . The Lancet Neurology, 15(6), 543-544.
- .
Preprints
- , JMIR Publications Inc..
- , Center for Open Science.
- , Springer Science and Business Media LLC.
- , Springer Science and Business Media LLC.
- , JMIR Publications Inc..
- , Cold Spring Harbor Laboratory.
- , JMIR Publications Inc..
- , Springer Science and Business Media LLC.
- , Springer Science and Business Media LLC.
- , Cold Spring Harbor Laboratory.
- , Cold Spring Harbor Laboratory.
- .
- .
- Research group
-
- Esther Hobson
- Alys Griffiths
- Theocharis Stavroulakis
- Liam Knox
- Mbombe Kazoka
- Stacy Young
- Lee Tuddenham
- Sarah Boddy
- Emily Mayberry
- Sean White
- Jade Howard
- Harry McDonnogh
- Madalina Roman
- Mary Sikonga
- Leslie Ing
- Lucy Musson
- Charlotte Massey
- Jon Street
- Sarah Roscoe
- Grants
-
Principal Funding Sources
- Motor Neurone Disease Association, UK
- National Institute of Health Research (NIHR)
- LifeArc
- My Name’5 Doddie Foundation
- European Union
- Professional activities and memberships
-
- Co-Director UK 51ݶ Research Institute (2022 onwards)
- Neuroscience Theme Lead at NIHR Sheffield Biomedical Research Centre (2022 onwards)
- NIHR Research Professor (2021-onwards)
- Head of Department, Neuroscience, University of Sheffield (2018-2022 onwards)
- Chair of Association of British Neurologists 51ݶ Special Interest Group (2017 onwards)
- Member of Association of British Neurologists Neuromuscular Advisory Group (2018-2022 onwards)
- Deputy Director of NIHR BRC Sheffield (2017-2022 onwards)
- External Examiner Neuroscience MSc, Kings College London (2016 -2020)
- Expert Advisor for NICE (2016 onwards)
- Charitable Trustee for Neurocare (2016 onwards)
- Group Leader for the International ALS Clinical Trials Guidelines (2015-2017).
- Chair of the NIHR DeNDRoN 51ݶ Clinical Studies Group (2015 onwards)
- Chair of the 51ݶ Association Clinical Advisory Board (2015 onwards)
- Member 51ݶ NICE Clinical Guidelines Development Group (2013 – 2016) and NICE Quality Assurance panel (2015 - 2016).
- Founding Course Leader – Clinical Neurology MSc, University of Sheffield (2011-2015)
- Clinical Lead for Neurology, Sheffield Teaching Hospitals (2012-2014)
- Member of NIHR RfPB (2010-2014) and 51ݶA healthcare research grant panels (2014 onwards).
- Representation of the Yorkshire and Humber region nationally on the Joint Royal College of Physician’s Specialty Advisory Committee (2008 - 2013).
- Training Programme Director for Neurology Yorkshire and Humber (2008-2012)
- Invited lectures
2017
- NICE Guidelines 1 year on Conference, London UK - Managing Symptoms in 51ݶ at the 51ݶ
- Association British Neurologists Meeting, Liverpool - Right to try
- 51ݶ Care Centre Meeting, Kettering - MyTube
- NIHR Annual CRF conference, Glasgow - User Centred Design
- Newcastle Neurosciences Meeting, Newcastle upon Tyne - 51ݶ A Journey through time and space
- 51ݶ Scotland meeting, Stirling - 51ݶ Clinical Research update
- Oxford Neurosciences Meeting, Oxford - 51ݶ Surviving the experts
2016
- Manchester Regional Neurosciences Centre – The evidence base for supportive Care in ALS.
- Newcastle upon Tyne, 51ݶ study day – Delivering evidence based care for individuals with ALS.
- Sheffield 51ݶ Study day – Recent developments in ALS care.
- St Christopher’s Hospice, London – Nutritional Care in ALS.
- Primary Care 2016, NEC, Birmingham – NICE guidelines for primary care.
2015
- British Thoracic Society, London – Diaphragmatic Pacing in ALS
- Difficult Lung Disease symposium, Sheffield – Neuromuscular disease for the respiratory physician.
- 51ݶA Care Centre meeting, Stafford - myNIV
- Association of palliative medicine neurological palliative care specialist interest forum, Manchester – What is new in 51ݶ.
- 1st UK PLS conference, Oxford – HSP and PLS
- WFN ALS meeting, Orlando – DiPALS results
2014
- 51ݶA Care Centre meeting, Stafford – Head Up
- Royal Society Medicine, London – The evidence base for symptomatic care in ALS
- 51ݶ Centre, Oxford – Update on symptomatic care.
- The Walton Centre, Liverpool - Update on symptomatic care.
- St Christopher’s Hospice, London – Head Up.
- Royal College of Physicians Regional Update, Sheffield – Neurology for the physician.
2013
- Plenary speaker: ENCALS, Sheffield - While we wait.
- 51ݶ Care Centre Directors meeting, Birmingham – Head Up and Secretion management
- St Christopher’s Hospice, London – Diaphragmatic Pacing
- The Walton Centre Regional Neurosciences Centre, Liverpool – Respiratory management of 51ݶ
2012
- Edinburgh Regional Neurosciences Centre - Respiratory management of 51ݶ
- Home Mechanical Ventilation Meeting, St Thomas Hospital, London – Role of Diaphragmatic Pacing
- Palliative Care Symposium, Leeds – Living with 51ݶ
- 51ݶA AGM – Developing the evidence base for clinical care in 51ݶ
2011
- Association of British Neurologists meeting – Clinical advances in 51ݶ
- European federation of neurological sciences, Lisbon – 51ݶ and its mimics
2010
- European Federation of Neurological Sciences, Rhodes - Lump or Split?
- 51ݶA Birmingham – Diaphragmatic Pacing in 51ݶ
- Nutrition Course, Leeds – Nutrition in 51ݶ
2009
- Leeds 51ݶA centre opening – Hereditary spastic paraparesis